Medical Science Liaison - Gyn Onc/Breast Cancer - California (CA, WA, OR)
BioNTech
- Cambridge, MA
- Permanent
- Full-time
- Act as member of BioNTech's US field based scientific/medical expert team delivering medical education, updates, and gaining insights from US HCPs
- Development of partnerships with investigators, thought leaders, and healthcare professionals involving scientific, evidence-based communication and education.
- Supporting and identifying US clinical trial sites and opportunities aligned with the overall oncology strategy.
- Documentation and communication of actionable insights gained in the field to relevant internal stakeholders.
- Provide Input, support and/or attendance at prioritized oncology conferences, medical educational programs, advisory boards, trainings.
- Ensure timely, accurate documentation of interactions, and compliance and safety reporting aligned with local policies.
- Advanced scientific degree required (i.e. PharmD, MD/DO or PhD preferred) with 3-5+ years of oncology MSL experience.
- Working therapeutic knowledge of gyn malignancies/breast cancer (with established HCP/external expert network).
- Preferred location: Los Angeles
- External customer focus with strong networking capabilities and engagement with the medical/scientific community.
- Excellent collaboration, networking, presentation and communication skills and a proven track record of cross-functional teamwork.
- Ability to manage multiple projects and adapt priorities according to business and strategic needs, with good understanding of clinical trials/protocols and drug development lifecycle management.
- Work with the highest ethical standards, with a working knowledge of relevant clinical regulations and industry standards, incl. Good Clinical Practice (GCP) guidelines and PhRMA Code on Interactions with Healthcare Professionals
- Proficiency with remote collaboration tools such as MS Teams, SharePoint, OneDrive, and other Office 365 applications
- Willingness and ability for frequent travel and driving within territory (50-70%)